Medico Remedies Ltd - 540937 - Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
Please find attached disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 by Mr. Haresh Kapurlal Mehta (Promoter) of the Company. Medico Remedies Ltd - 540937 - Disclosure Under Regulation 29(1) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
In terms of Regulation 29(1) of SEBI (SAST) Regulations, we hereby enclose disclosure submitted by Mr. Haresh Kapurlal Mehta (Promoter) with regards to the acquisition of 98,72,000 equity shares of the Company on 1st November, 2023. Medico Remedies Ltd - 540937 - Submission Of Disclosure Of Inter-Se Transfer Of Shares Between The Promoter/Promoter Group Pursuant To Regulation 10(6) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
In terms of Regulation 10(6) of SEBI (SAST) Regulations, we hereby submit enclosure disclosure submitted by Mr. Haresh Kapurlal Mehta with regards to acquisition of 98,72,000 equity shares of the Company on 1st November, 2023. Medico Remedies Ltd - 540937 - Board Meeting Intimation for Notice Of The Board Meeting
Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 ,inter alia, to consider and approve Unaudited Financial Results for the quarter and half year ended 30th September, 2023 along with the Limited Review Report thereon Medico Remedies Ltd - 540937 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Haresh Kapurlal Mehta Medico Remedies Ltd - 540937 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rita Hitesh Mehta & Others Medico Remedies Ltd - 540937 - Disclosure Of Inter-Se Transfer Of Shares Between The Promoter/Promoter Group Pursuant To Regulation 10(5) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
Please find attached disclosure under Regulation 10(5) of SEBI (SAST) Regulations, 2011 received from Mr. Haresh Mehta ( Acquirer). Medico Remedies Ltd - 540937 - Intimation Of Cancellation Of Inter-Se Transfer Of Shares Amongst Promoter And Promoter Group Pursuant To Regulation 10(5) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
With reference to the above mentioned disclosure submitted to the Stock Exchanges by the Promoters and Promoter Group on 18th October, 2023 regarding proposed Inter-se transfer of shares, we hereby state that the said proposed inter-se transfer of shares hereby stands cancelled and the necessary disclosure is attached herewith. Medico Remedies Ltd - 540937 - Disclosure Of Inter-Se Transfer Of Shares Between The Promoter/Promoter Group Pursuant To Regulation 10(5) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
Pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations, 2015 read with Regulation 3 of SEBI (PIT) Regulations, 2015, we would like to inform you that the Company has received information about the dissolution and full partition of Haresh Kapurlal Mehta HUF, member of promoter group. Medico Remedies Ltd - 540937 - Closure of Trading Window
Pursuant to SEBI (PIT) Regulations, 2015, The Trading Window for dealing in equity shares of the Company will be closed for all Insiders, Designated Persons and their immediate relatives from 1st October, 2023 up to the expiry of 48 hours post the declaration of Unaudited Financial results for the quarter and half year ended 30th September, 2023.